• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移性至胃的小细胞肺癌:常被忽视,治疗选择有限。

Small cell lung carcinoma metastatic to the stomach: Commonly overlooked, limited treatment options.

作者信息

Moyana Terence N

机构信息

Diagnostic and Molecular Pathology, The Ottawa Hospital and University of Ottawa, Ottawa K1H 8L6, Ontario, Canada.

出版信息

World J Gastroenterol. 2024 Dec 28;30(48):5198-5204. doi: 10.3748/wjg.v30.i48.5198.

DOI:10.3748/wjg.v30.i48.5198
PMID:39735276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11612703/
Abstract

Small cell lung carcinoma metastatic to the stomach, whether synchronous or metachronous, is a rare phenomenon accounting for < 0.5% of lung cancers. Hence it can be overlooked by clinicians resulting in delayed diagnosis. This manuscript comments on Yang 's article which reported 3 such cases. The main diagnostic features are based on routine morphology comprised of small cells with hyperchromatic nuclei, scant cytoplasm, brisk mitoses and necrosis. This can be supplemented by immunohistochemistry demonstrating positivity for cytokeratin, thyroid transcription factor-1 and neuroendocrine markers as well as a high Ki-67 labelling index. Imaging modalities such as positron emission tomography/contrast computed tomography help to confirm lung origin and rule out the possibility of extra-pulmonary small cell carcinoma. The predominant mechanism of spread is most likely hematogeneous. Prognosis is generally poor since this represents stage 4 disease but survival can be improved by chemo/radiotherapy and palliative surgery in select cases. Though outcomes have not changed much in the last several decades, the recent Food and Drug Administration approval of immune checkpoint inhibitors was a significant milestone as was the delineation of small cell lung carcinoma molecular subtypes. Liquid biopsies are increasingly being used for biomarker studies in clinical trials to assess treatment response and prognosis.

摘要

小细胞肺癌转移至胃,无论是同时性还是异时性转移,都是一种罕见现象,占肺癌的比例不到0.5%。因此,临床医生可能会忽视它,导致诊断延迟。本文对Yang报道3例此类病例的文章进行评论。主要诊断特征基于常规形态学,包括细胞核深染、胞质稀少、有丝分裂活跃和坏死的小细胞。免疫组织化学显示细胞角蛋白、甲状腺转录因子-1和神经内分泌标志物呈阳性,以及高Ki-67标记指数可作为补充。正电子发射断层扫描/对比计算机断层扫描等成像方式有助于确认肺部起源,并排除肺外小细胞癌的可能性。主要的转移机制很可能是血行转移。由于这代表IV期疾病,预后通常较差,但在某些病例中,化疗/放疗和姑息性手术可改善生存率。尽管在过去几十年中结果变化不大,但最近美国食品药品监督管理局批准免疫检查点抑制剂是一个重要的里程碑,小细胞肺癌分子亚型的划分也是如此。液体活检越来越多地用于临床试验中的生物标志物研究,以评估治疗反应和预后。

相似文献

1
Small cell lung carcinoma metastatic to the stomach: Commonly overlooked, limited treatment options.转移性至胃的小细胞肺癌:常被忽视,治疗选择有限。
World J Gastroenterol. 2024 Dec 28;30(48):5198-5204. doi: 10.3748/wjg.v30.i48.5198.
2
Small cell lung carcinoma: staging, imaging, and treatment considerations.小细胞肺癌:分期、影像学及治疗考量
Radiographics. 2014 Oct;34(6):1707-21. doi: 10.1148/rg.346140178.
3
Synchronous primary lung cancer presenting with small cell carcinoma and adenocarcinoma.同步出现小细胞癌和腺癌的原发性肺癌
Ann Thorac Cardiovasc Surg. 2015;21(2):183-7. doi: 10.5761/atcs.cr.14-00207. Epub 2015 Mar 31.
4
Radiation and Systemic Therapy for Limited-Stage Small-Cell Lung Cancer.局限期小细胞肺癌的放疗和全身治疗。
J Clin Oncol. 2022 Feb 20;40(6):661-670. doi: 10.1200/JCO.21.01639. Epub 2022 Jan 5.
5
Construction of a prognostic model for extensive-stage small cell lung cancer patients undergoing immune therapy in northernmost China and prediction of treatment efficacy based on response status at different time points.构建中国最北部广泛期小细胞肺癌患者接受免疫治疗的预后模型,并基于不同时间点的反应状态预测治疗效果。
J Cancer Res Clin Oncol. 2024 May 15;150(5):255. doi: 10.1007/s00432-024-05767-6.
6
Gastric metastasis from small cell lung cancer: a case report.小细胞肺癌胃转移:一例报告
World J Gastroenterol. 2015 Feb 7;21(5):1684-8. doi: 10.3748/wjg.v21.i5.1684.
7
PD-L1 Expression in Small Cell and Large Cell Neuroendocrine Carcinomas of Lung: an Immunohistochemical Study with Review of Literature.肺的小细胞和大细胞神经内分泌癌中 PD-L1 的表达:一项免疫组化研究并文献复习。
Pathol Oncol Res. 2020 Oct;26(4):2363-2370. doi: 10.1007/s12253-020-00832-0. Epub 2020 Jun 6.
8
F-Fludeoxyglucose PET/CT in SCLC: Analysis of the CONVERT Randomized Controlled Trial.氟代脱氧葡萄糖 PET/CT 用于小细胞肺癌:CONVERT 随机对照试验分析。
J Thorac Oncol. 2019 Jul;14(7):1296-1305. doi: 10.1016/j.jtho.2019.03.023. Epub 2019 Apr 16.
9
Defining limited stage small cell lung cancer: a radiation oncologist's perspective.定义局限期小细胞肺癌:放疗肿瘤学家的观点。
BMJ Case Rep. 2018 Jan 17;2018:bcr-2017-223708. doi: 10.1136/bcr-2017-223708.
10
Staging and imaging of small cell lung cancer.小细胞肺癌的分期和影像学检查。
Cancer Imaging. 2012 Jan 12;11(1):253-8. doi: 10.1102/1470-7330.2011.0036.

本文引用的文献

1
SMARCA4 and SMARCA2 co-deficiency: An uncommon molecular signature defining a subset of rare, aggressive and undifferentiated malignancies associated with defective chromatin remodeling.SMARCA4 和 SMARCA2 共缺失:一种罕见的分子特征,定义了一组与染色质重塑缺陷相关的罕见、侵袭性和未分化恶性肿瘤亚群。
Cancer Lett. 2024 Nov 28;605:217282. doi: 10.1016/j.canlet.2024.217282. Epub 2024 Oct 4.
2
Cell-free and extrachromosomal DNA profiling of small cell lung cancer.小细胞肺癌的游离和染色体外DNA分析
Trends Mol Med. 2025 Jan;31(1):64-78. doi: 10.1016/j.molmed.2024.08.004. Epub 2024 Sep 4.
3
Gastric metastasis of small cell lung carcinoma: Three case reports and review of literature.胃小细胞肺癌转移:三例病例报告及文献复习。
World J Gastroenterol. 2024 Aug 21;30(31):3717-3725. doi: 10.3748/wjg.v30.i31.3717.
4
Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial.本美司他滨、安罗替尼联合化疗治疗广泛期小细胞肺癌的随机 3 期临床试验。
Nat Med. 2024 Oct;30(10):2967-2976. doi: 10.1038/s41591-024-03132-1. Epub 2024 Jul 11.
5
Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer.小细胞肺癌分子特征和治疗靶点的新进展。
Nat Rev Clin Oncol. 2024 Aug;21(8):610-627. doi: 10.1038/s41571-024-00914-x. Epub 2024 Jul 4.
6
Head-to-head: Should Ki67 proliferation index be included in the formal classification of pulmonary neuroendocrine neoplasms?头对头比较:Ki67 增殖指数是否应纳入肺神经内分泌肿瘤的正式分类?
Histopathology. 2024 Oct;85(4):535-548. doi: 10.1111/his.15206. Epub 2024 May 10.
7
Durvalumab ± Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden.度伐利尤单抗 ± 替西木单抗联合铂类依托泊苷治疗广泛期小细胞肺癌(CASPIAN):基于 PD-L1 表达和组织肿瘤突变负荷的结果。
Clin Cancer Res. 2024 Feb 16;30(4):824-835. doi: 10.1158/1078-0432.CCR-23-1689.
8
Updates on lung neuroendocrine neoplasm classification.肺神经内分泌肿瘤分类的最新进展。
Histopathology. 2024 Jan;84(1):67-85. doi: 10.1111/his.15058. Epub 2023 Oct 4.
9
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions.小细胞肺癌的临床洞察:肿瘤异质性、诊断、治疗和未来方向。
CA Cancer J Clin. 2023 Nov-Dec;73(6):620-652. doi: 10.3322/caac.21785. Epub 2023 Jun 17.
10
Antibody-Drug Conjugates in Lung Cancer: Recent Advances and Implementing Strategies.抗体药物偶联物在肺癌中的应用:最新进展与实施策略。
J Clin Oncol. 2023 Jul 20;41(21):3747-3761. doi: 10.1200/JCO.23.00013. Epub 2023 May 24.